Mella O - Search Results

1

[High dose therapy with autologous stem cell support in malignant disorders. Excerpt from the statement by the advisory group of the State Health Services].

Holte H, Kvaløy SO, Engan T, Evensen SA, Mella O, Tangen JM, Wesenberg F, Wist EA. Holte H, et al. Among authors: mella o. Tidsskr Nor Laegeforen. 1996 Sep 10;116(21):2577-81. Tidsskr Nor Laegeforen. 1996. PMID: 8928130 Norwegian.

2

[Should alternative therapists treat cancer--what is the opinion of oncology health personnel?].

Risberg T, Kolstad A, Wist EA, Holte H, Mella O, Klepp O. Risberg T, et al. Among authors: mella o. Tidsskr Nor Laegeforen. 2003 Nov 6;123(21):3059-61. Tidsskr Nor Laegeforen. 2003. PMID: 14618177 Free article. Norwegian.

3

[Should complementary therapies be offered in hospitals?].

Risberg T, Bremnes Y, Kolstad A, Holte H, Wist E, Mella O, Klepp O. Risberg T, et al. Among authors: mella o. Tidsskr Nor Laegeforen. 2004 Dec 2;124(23):3078-80. Tidsskr Nor Laegeforen. 2004. PMID: 15586193 Free article. Norwegian.

4

Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway.

Kolstad A, Risberg T, Bremnes Y, Wilsgaard T, Holte H, Klepp O, Mella O, Wist E. Kolstad A, et al. Among authors: mella o. Support Care Cancer. 2004 May;12(5):312-8. doi: 10.1007/s00520-004-0590-9. Epub 2004 Feb 6. Support Care Cancer. 2004. PMID: 14767750

5

ChlVPP is as effective as alternating ChlVPP/ABOD in advanced stage Hodgkin's disease.

Holte H, Mella O, Wist E, Telhaug R, Hannisdal E, Abrahamsen AF. Holte H, et al. Among authors: mella o. Acta Oncol. 1996;35 Suppl 8:73-80. doi: 10.3109/02841869609098523. Acta Oncol. 1996. PMID: 9073051 Clinical Trial.

6

Droloxifene--a new anti-estrogen. A phase II study in advanced breast cancer.

Haarstad H, Gundersen S, Wist E, Raabe N, Mella O, Kvinnsland S. Haarstad H, et al. Among authors: mella o. Acta Oncol. 1992;31(4):425-8. doi: 10.3109/02841869209088284. Acta Oncol. 1992. PMID: 1632978 Clinical Trial.

7

Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in Norway.

Risberg T, Kolstad A, Bremnes Y, Holte H, Wist EA, Mella O, Klepp O, Wilsgaard T, Cassileth BR. Risberg T, et al. Among authors: mella o. Eur J Cancer. 2004 Mar;40(4):529-35. doi: 10.1016/j.ejca.2003.11.011. Eur J Cancer. 2004. PMID: 14962719

8

[Nausea and vomiting during treatment with cytostatics].

Kaasa S, Mella O, Kvikstad A. Kaasa S, et al. Among authors: mella o. Tidsskr Nor Laegeforen. 1991 Mar 20;111(8):941-4. Tidsskr Nor Laegeforen. 1991. PMID: 2042209 Review. Norwegian.

9

[Half-body irradiation. An effective palliative treatment of widespread skeletal metastases].

Schem BC, Mella O, Dahl O. Schem BC, et al. Among authors: mella o. Tidsskr Nor Laegeforen. 1992 Nov 10;112(27):3446-9. Tidsskr Nor Laegeforen. 1992. PMID: 1281342 Norwegian.

10

[Breast conserving surgery in breast cancer. Experiences from the Haukeland Hospital 1983-88].

Aas T, Valen B, Varhaug JE, Mella O. Aas T, et al. Among authors: mella o. Tidsskr Nor Laegeforen. 1990 Jan 20;110(2):196-200. Tidsskr Nor Laegeforen. 1990. PMID: 2154063 Norwegian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters